A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
A snowflake-shaped nanoparticle greatly enhanced the combination of radiotherapy and immunotherapy in mouse models of prostate cancer.
The drug rucaparib significantly delayed cancer progression for women with ovarian cancer and may be an effective option for maintenance therapy, according to findings from a recent clinical trial.
A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.
Men with advanced prostate cancer who were treated based on the genetic makeup of their cancer survived significantly longer than those treated with standard treatments, according to a new study.
Inhibiting an epigenetic regulator called DOT1L could be a key to slowing treatment-resistant prostate cancer, according to a recent Northwestern Medicine study.
Biomarkers using mass cytometry can assess patient response to an emerging treatment for pediatric brain tumors, according to a recent multi-center study.
A new combination therapy targeting breast cancer tumors in the brain dramatically decreased tumor size and increased survival in mice, according to a new study.